Press Room

 

CAPD Statement on the Administration’s Executive Order on Rebates

Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the Administration’s new Executive Order on…

CAPD Comment Letter on CMS Rule on Drug Utilization Review and Value-Based Purchasing (2482-P)

Monday, July 20, 2020 Seema Verma, AdministratorCenters for Medicare and Medicaid ServicesDepartment of Health and Human ServicesAttention: CMS-2482-PP.O….

CAPD Comment Letter on CMS-4190-P

Seema Verma, Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-4190-P P.O….

CAPD Comment Letter on HHS’ Notice of Benefit and Payment Parameters (NBPP)

Seema Verma, Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-9916-P P.O….

CAPD Statement on House Passage of H.R. 3

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on the passage…

CAPD Statement on the U.S. Chamber Letter on Health Care Pricing Proposals

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on the U.S….

CAPD Statement on PBM Transparency Bills

Today, Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs, released the following statement on the…

Ahead of Congressional Hearings on Drug Pricing, CAPD Calls on Lawmakers to Address Big Pharma’s Tactics to Delay Competition

Today, Americans are paying high monopoly prices for many of their brand prescription drugs due to a lack…